Our Science

Publications and Presentations

search
Date
Title
April 2019
Successful Treatment of Two Patients with Candida auris Candidemia with the Investigational Agent, Oral Ibrexafungerp (formerly SCY-078), from the CARES Study D Juneja, O Singh, B Tarai, DA Angulo
ECCMID 2019
April 2019
Favourable Clinical Outcome of Two Patients with Candida spp. Spondylodiscitis treated with Oral Ibrexafungerp (formerly SCY-078) from the FURI Study Philipp Koehler, Oliver A. Cornerly, David Angulo
ECCMID 2019
April 2019
Use of Ibrexafungerp (formerly SCY-078) to Treat Severe Azole Refractory Esophageal Candidiasis. A Case Report from the Furi Study J Vazquez, Aprile Osborn, D Angulo
ECCMID 2019
April 2019
Penetration of Ibrexafungerp (formerly SCY-078) versus Micafungin at the Site of Infection in an Intra-abdominal Candidiasis Mouse Model Annie Lee, Brendan Prideaux, Min Hee Lee, Matthew Zimmerman, Padmaja Paderu, Stephen A. Barat, David Angulo, David S. Perlin, Yanan Zhao
ECCMID 2019
April 2019
Efficacy of Ibrexafungerp (formerly SCY-078) Against Pneumocystis Pneumonia in a Murine Therapeutic Model. Stephen A. Barat, Katyna Borroto-Esoda, David A. Angulo, Alan Ashbaugh, Melanie Cushion
ECCMID 2019
March 2019
Ibrexafungerp: Activity against Pneumocystis S. Barat
Superbugs and Superdrugs 2019
September 2018
Ibrexafungerp (formerly SCY-078) Displays Potent In Vitro Activity Against C. glabrata Isolates with Mutations in fks Genes Stephen Barat, Katyna Borroto-Esoda, David Angulo
ESCMID ASM 2018
June 2018
SCY-078: A first-in-class, orally-bioavailable, glucan synthase inhibitor has broad spectrum activity against Candida, Aspergillus and Pneumocystis spp. Stephen Barat, Katyna Borroto-Esoda, David Angulo
ISHAM 2018
June 2018
In vitro Activity of SCY-078 in Combination with Isavuconazole or Amphotericin B against Medically Important Moulds V. Petraitis, P. Kavaliauskas, R. Planciuniene, M.Viragailis, R.Petraitiene, S.Barat, K. Borroto-Esoada, D. Angulo, T. Walsh
ASM Microbe 2018
February 2018
Combination Therapy with SCY-078 and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis V. Petraitis, S. Barat, K. Borroto-Esoda, D. Angulo, T. Walsh
AAA 2018
< PrevNext >